EARLY CONFIRMED TOP INDUSTRY Speakers
Kate Adcock, Director of Research and Innovation, The Muscular Dystrophy U.K.
Jeonghoon Ahn, Director, National Evidence-based Healthcare Collaborating Agency
Tanya Aiden, Global Products Lead, BIOCAD
John Alter, Vice President Pricing And Market Access, Pfizer
Mauricio Alvarez Reyes, Market Access Expert, Independent
Sofie Alverlind, Project Manager, Swedish Association of Local Authorities and Regions
Ines Alves, President, ANDO Portugal
Diego Ardigo, R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA
Francis Arickx, Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy, National Institute for Health and Disability Insurance RIZIV-INAMI
Ramesh Arjunji, Senior Director Heor And Rwe, AveXis
Nadeem Ashraf, Medical Advisor - Diabetes, N/A
Kagan Atikeler, Pharmacist, Turkish Medicines and Medical Devices Agency
Antje Behring, Acting Head, Federal Joint Committee
Inge Bliestle, Chief Operating Officer, TolerogenixX
Nadia Bodkin, Rare Disease Advocacy Professional, Rare Advocacy Movement
Axel Boehnke, Director Market Access EU North, PTC Therapeutics
Luc Boileau, Chairman and Chief Executive Officer, Inesss
Hassan Bruneo, Associate Director, Alnylam Switzerland Gmbh
Anna Bucsics, Project Advisor, MoCA - Mechanism of Coordinated Access to Orphan M
Rob Burley, Director of Campaigns, Care & Support, The Muscular Dystrophy U.K.
Nicki Catterick, Senior Director, Global Market Access and Pricing, Merck Group
David Catterick, Health Economics Senior Manager, Amgen
Sandro Cesaro-Tadic, Head Pricing I8 & Product Pricing Strategies, Roche
Anjan Chatterjee, Global Head Of Real World Evidence, Boehringer Ingelheim Pharma GmbH & Co. KG
Americo Cicchetti, Director, Universita Cattolica Del Sacro Cuore
Ali Ciger, Commercial Director, Pain, Pfizer
Francis Crawley, Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer), Good Clinical Practice Alliance (GCPA)
Omar Dabbous, VP, Health Economics And Outcomes Research, AveXis
Charles De Cidrac, Director Of Health Insurance, AXA
Carla Deakin, Programme Director - Commercial And Managed Access, NICE
Olga Diachenko, Market Access Manager Europe, Accord Healthcare
Valentin Dodonov, Deputy General Head Of Market Access, BIOCAD
Mark Duman, Nw Service Champion, Diabetes U.K.
Rudy Dupree, Senior Project Manager, Eunethta Wp4, EUnetHTA
Jenny Ebert, National Account Director, Genzyme Sanofi Corp
Gottfried Endel, EBM, HTA Team Leader, H.V.B.
Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband
Valerie Faillat, Head Of Sanofi Espoir Foundation, SANOFI
Rute Fernandes, Head of Rare Diseases of Europe and Canada, Takeda
Girisha Fernando, CEO, Lyfegen HealthTech AG
Martina Flammer, Senior Vice President, Head Of Corporate Customer Value, Boehringer-Ingelheim
Oliver Gassner, Head Digital Health Intelligence | Emea, Bayer
Katrien Van Geyt, Head of Market Access, Belgium & Luxembourg, Takeda
Fabrizio Gianfrate, Professor of Health Economics, Mkt Access Advisor, Universities of Rome and Ferrara
Josie Godfrey, Director, JG Zebra Consulting
Wim Goettsch, Special HTA-advisor, Zorginstituut
Clare Hague, Therapy Area Market Access Lead, Hematology, Janssen Pharmaceutical
Stephen Hall, Knowledge Exchange Associate, NIHR Innovation Observatory, Newcastle University
Adam Heathfield, Senior Director of Global Health And Value Innovation Centre, Pfizer Ltd
Stefan Holmstrom, Head, HTA Strategy and PRO excellence, Astellas Pharma
Birgit Holz, Global Head Of Contracting Innovation, Sanofi
Patrick Hopkinson, Executive Director, Wwheor Markets, Bristol-Myers Squibb
Nigel Hughes, Scientific Director, RMEDS Quantitative Sciences,, Janssen
Wills Hughes-Wilson, Head Of Patient Access And Commercial Planning, Mereo BioPharma
Kankendria Ingram, Independent, Independent
Dawn Torrence Ireland, President And Founder, C.H.E.R.U.B.S.
Ulrike Jacobi, Head Of External Affairs And Market Access, Amgen
David Jakouloff, Global Head Of Market Access, Dmd, PTC Therapeutics
Rasmus Jensen, Global Head Of Market Access, Camurus
Wendy Jory, Head Of Global Pricing Centre Of Excellence, GlaxoSmithKline
Navin Joshi, Global Head of Pricing, Classic & Established Products. Global Pharma, Head of Pricing & Access Capabilities, Emerging Markets, GlaxoSmithKline
Marcela Junqueira, Head Of Strategic Affairs And Health Economics, The Janssen Pharmaceutical
Lisette Kaskens, Global Head Of Pricing And Market Access, Ferrer
Jolanda Koenders, Head Of Pricing And Market Access Pharma, Novartis
Shanthy Krishnaraja, Sr. Director, Market Access and Strategy, Seqirus
Adam Kundzewicz, Senior Global Payer Strategy Manager, Head Of Pricing, Boehringer Ingelheim Pharma GmbH & Co. KG
Marie-Liesse Le Corfec, Global Portfolio Marketing Head, Ps, B.D. Pharmaceuticals Systems
Jost Leemhuis, Head of Safety Science, Roche
Sandy Leonard, Vice President Of Medical Evidence And Observational Research, AstraZeneca
Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer
Gavin Lewis, Vice President Of Value, Access And Policy, Amgen
Sune Lindgaard, Chief Of Business Intelligence, Amgros, Denmark
Catarina Lopes Pereira, Market Access Manager, Medicines for Europe
Mark Macgregor, Co-Vice Chair, Scottish Medicines Consortium, Nhs Scotland
Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway
Joerg Mahlich, Head of Health, Janssen Pharmaceutical K.K.
Andrea Mantovani, Former Head of Value, Access & Policy for Biopharma Companies, Independent
Marco Marchetti, Director Of The National Center For Health Technology Assessment, Istituto Superiore di Sanita
Anne Marciniak, Head Of Market Access, Europe, Aimmune
Cristina Martin-Rinconada, Head Of Value And Access For International Partners Markets (Mena And Ceer Regions), Biogen
Kevin Mayo, Global Head Of Market Access And New Products, PTC Therapeutics
Vipul Modi, Head of Transformation for Innovation, Digital and Life Sciences, Oxford Academic Health Science Network
Patrick Mollon, HEOR Consultant, GMAP, Ipsen Pharma
Tal Morginstin, Director, Nlhs (National List Of Health Services) Assessment Division, Ministry of Health
Thomas Mueller, Head Of Directorate General 1 "Drugs, Medical Devices, Biotechnology", Federal Ministry of Health Germany
Michael Müller, Head of Market Access, Western Europe, Sun Pharma
Peter Mulley, Director Global Market Access, ViiV Healthcare
Diane Munch, Head Of Global Pricing, Patient And Health Impact, Pfizer
Nuriya Musina, Head of Development, Federal State Budgetary Institution, the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the R
Hanadi Nahas, Chairman And General Manager, Access Core
Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)
Enkeleida Nikai, Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea), Janssen Pharmaceutical
Waldemar Ockert, Director, Rwi Business Market Analytics, Astellas Pharma
Irina Odnoletkova, Vice President Health Technology Assessment, Apogenix Gmbh
Laura O'Hanlon, Associate Director, International Market Access/Reimbursement, Myriad genetics
Melvin Olson, Global Head Rwd Strategy And Innovation, Novartis Pharma
Robert Orzechowski, Chief Operating Officer, Lancaster Cancer Centre
Arrigo Paciello, Scientific Advisor, AIFA
Melissa Paige, Uva Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate, U.V.A. Health System
Ana Palma, Senior Director Global Hta And Patient Access Lead, Sobi
Elena Panitti, Global Rwe Capability Building Lead, Novartis
Detlev Parow, Head Pharmaceutical Department, D.A.K.
Chris Pashos, Vice President Of Global Evidence Strategy, AbbVie
Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim
Andres Pichon Riviere, Executive Director And Director Of Health Technology Assessment And Economic Evaluations, I.E.C.S.
Lara Pippo, Head Of Market Access, CSL Behring
Sarah Pitluck, Head, Global Pricing And Reimbursement, Spark Therapeutics
Robert Popovian, Vice President Of Government Relations, Pfizer
Diann Potestio, Vice President Market Access, Ascendis Pharma
Martin Price, Vice President Of Health Economics, Market Access And Reimbursement, Johnson & Johnson
Andrew Richards, Head Of Global Market Access And Pricing, Ferring
Kevin Rieger, Head Of Eu Affairs, BPI
Juan Roman, Head of Market Access & Pricing, Acceleron Pharmaceuticals, Inc.
Giuseppe Rosano, Member Of The Cardiovascular Working Party, European Medicines Agency
Micah Rose, Senior Scientific Adviser, Health Economic Modelling, National Institute for Health and Care Excellence
Igor Rudychev, Head of US Digital, Data, and Innovations, AstraZeneca
Peter Rutherford, Global Medical Lead Of Orphan Renal Diseases, Vifor Pharma Group
Ryan Saadi, Vice President, Global Market Access, CSL Behring
Rasha Salama, Ministry Public Health Consultant and Advisor, Ministry Of Health
Steve Sandor, Vice President, Market Access And Trade, Paratek Pharmaceuticals , Inc.
Gustavo Saraiva Dos Anjos, Global Market Access Director for Biologics, GlaxoSmithKline
Gundula Schneidewind, Head Ethics And Compliance, Europe And Canada, Takeda
Michael Schroter, Partner, Viopas Partners
Ad Schuurman, Senior Advisor International Affairs, National Health Care Institute (ZIN), the Netherlands
Nabil Seidov, Deputy Head of Department for Health Policy and Planning of Public Health and Reforms Centre, Ministry of Healthcare of Azerbaijan Republic
Ayman Semaan, Head Of Market Access, Algorithm
Simon Shohet, Senior Director, Global Market Access And Pricing, Ipsen
Rita Shorjian, Market Access Head - Near East & North West Africa, AbbVie
Dorinda Silva, Volunteer Patient Advocate, Portuguese Association for CDG and other Rare Metabolic Diseases
Tamir Singer, Head Of Commercial Development, Specialised Commissioning, NHS England
Ulf Staginnus, Senior Vice President, Head Of Global Market Access And Pricing, Ipsen Pharma
Anastasiya Stepanova, State Authorities Manager, JSC Nizhpharm
Richard Stephens, Patient Advocate, National Cancer Research Institute (NCRI)
Giovanni Tafuri, EUnetHTA, Senior Scientific Officer, National Health Care Institute (ZIN), the Netherlands
Bertrand Tardivel, General Manager, Frehel GmbH
Samuel Taylor, Emerging Markets Pricing Lead, Pfizer
Renske Ten Ham, Researcher, Utrecht University
Gwilym Thompson, Director Worldwide Heor, BMS
Daria Tolkacheva, Head Of Health Economics, JSC BIOCAD
Jorg Tomeczkowski, Head Of Market Access, Janssen Cilag Germany
Keiko Tone, Vice President Global Market Access, Shionogi Inc
Ariella Toren, Director Of Medicine And Medical Technologies, Hmos Department, Israel - Ministry Of Health
Maarten Van Baelen, Market Access Director, Medicines
Bart Van Den Daele, Head of External Affairs – Director Market Access, Gilead Sciences
Goedele Van Haasteren, Hta Specialist, Swiss Federal Office of Public Health
Evert Jan Van Lente, Director of EU Affairs, AOK Bundesverdand
Christina Vandoros, Director, Macroeconomics & Health Policy - Emea, Janssen
Stefan Vegter, Market Access Manager, Novartis
Entela Xoxi, Former Aifa, Universita Cattolica Del Sacro Cuore
Natasa Zibelnik, Global Head of Market Access, E.U.S.A. Pharma
Martine Zimmermann, Global Head Of Regulatory Affairs, Alexion Pharmaceuticals
Fabrizio Zucca, Director Patient Access Dach, Sobi
Contact us
To sponsor or exhibit:
Edmond Rama
+44 (0)207 092 1052
edmond.rama@terrapinn.com
To speak:
Chris Shanks
+44 (0)207 092 1151
chris.shanks@terrapinn.com
Organiser
